Kevin Xu Joins CGI Winter Meeting to Drive Global Health Solutions
Kevin Xu, Chairman of MEBO Group, was recently invited to the Clinton Global Initiative (CGI) Winter Meeting in New York, where he met with former U.S. President Bill Clinton. The meeting attracted global leaders from politics, business, and academia to discuss critical topics like public health, climate change, and inclusive economic growth. As a committed partner of the Clinton Foundation for over a decade, MEBO Group continues to play a significant role in shaping global health development.
Impactful Collaborations with the Clinton Foundation
Since 2014, MEBO Group has worked closely with the Clinton Foundation on several high-impact initiatives, including" From Urban to Rural: Training Doctors on Moist Exposed Burn Therapy (MEBT)," "Wave of Restoration: New MEBT Training in Latin America," "Mending Europe: Empowering the establishment of regeneration network," and "COVID-19 Student Action Fund." These efforts highlight MEBO's commitment to advancing healthcare solutions worldwide.
Driving Change in Global Health Governance
Bill Clinton has often praised Kevin Xu and MEBO Group for their innovative contributions to solving global health challenges. Over the past ten years, MEBO has become a key player in global health governance, offering replicable solutions for sustainable medical aid.
CGI’s Role in Shaping Global Solutions
Since its inception in 2005, the CGI has been instrumental in fostering cross-sector collaboration. With over 4,100 global projects improving the lives of 430 million people, the CGI's Winter Meeting continues to be a platform for driving progress toward the United Nations' 2030 Sustainable Development Goals.
About MEBO
Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.
At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.
As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.